Skip to content

Side effects and safety: Spravato, ketamine and TMS

The common, the uncommon and the serious side effects of each treatment, who should not have them, and what clinics monitor.

Updated · Checked by the Covered Mind editorial team against cited sources

Key facts

  • Last checked:
  • Sources listed: 2
  • Reading time: About 2 minutes
Key facts
FactValue
Last checked
Sources listed2
Reading timeAbout 2 minutes

Spravato (esketamine)

Check Spravato, ketamine, and TMS coverage in the coverage checker and read coverage rules by insurer. Common questions about coverage and billing are answered on the Spravato overview.

Common: dissociation, dizziness, nausea, sedation, feeling drunk, numbness, anxiety, increased blood pressure. Most last under two hours. Serious: the boxed warning covers sedation, dissociation, respiratory depression, and misuse. Blood pressure spikes are why monitoring is mandatory. Do not use with: aneurysm or arteriovenous malformation, history of intracerebral hemorrhage, uncontrolled hypertension, pregnancy. Long term: bladder symptoms and cognitive effects have been seen with heavy recreational ketamine use; they have not appeared at treatment doses in the trials, but clinics ask about urinary symptoms at every visit.

Read What to expect at your first Spravato session.

How do ketamine side effects compare?

Same profile as Spravato with dose-dependent intensity. Additional considerations: IV dosing can raise blood pressure more sharply; oral and at-home use carries a higher misuse risk because dosing is less supervised. Liver enzyme elevation is rare. Interactions: benzodiazepines and lamotrigine reduce the effect; MAOIs and stimulants raise cardiovascular risk.

See IV ketamine vs at-home ketamine and What to expect at your first ketamine infusion.

TMS (transcranial magnetic stimulation)

Common: scalp discomfort and headache during the first week; facial muscle twitching during pulses. Uncommon: hearing changes without earplugs (always wear them), transient mood elevation in people with bipolar disorder. Serious: seizure, roughly 1 in 1,000 patients or less, mostly in people with risk factors. Screening covers epilepsy, brain injury, and medications that lower seizure threshold. Do not use with: non-removable ferromagnetic metal in the head (some aneurysm clips, cochlear implants, certain stents), or implanted devices within 30 cm of the coil.

TMS: the complete guide walks through screening and a full course.

Read TMS for PTSD.

What good monitoring looks like

  • Blood pressure before and after every ketamine or Spravato dose.
  • A rating scale at baseline and at intervals, so a treatment that is not working gets stopped.
  • Questions about bladder symptoms, substance use and driving at every visit.
  • For TMS, motor threshold rechecked if pulses feel different.

To check how a clinic handles each of these, bring Questions to ask a Spravato, ketamine or TMS clinic to your consult.

What are the driving rules after treatment?

Federal law requires two hours of observation after Spravato and prohibits driving until the next day. Clinics apply the same rule to ketamine. TMS has no driving restriction. See driving and monitoring rules.

Checked by the Covered Mind editorial team · · Editorial policy

Cite this

Covered Mind. "Side effects and safety: Spravato, ketamine and TMS." https://www.coveredmind.com/guides/side-effects-and-safety. Last checked Sep 1, 2026.

This site provides general information about insurance coverage and treatment options. It is not medical advice, not a guarantee of coverage, and not a substitute for talking with a clinician or your health plan.